$0.87
14.77%
Nasdaq, Nov 06, 04:00 pm EST. Closed.
ISIN
IL0011651580
Symbol
PRFX

PainReform Ltd Stock price

$0.87
-0.01 1.06% 1M
-1.04 54.40% 6M
-2.34 72.86% YTD
-4.53 83.87% 1Y
-308.73 99.72% 3Y
-3,167.13 99.97% 5Y
-8,087.13 99.99% 10Y
-8,087.13 99.99% 20Y
Nasdaq, Closing price Fri, Nov 06 2026
+0.11 14.77%
ISIN
IL0011651580
Symbol
PRFX
Industry

Is PainReform Ltd a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,093 stocks worldwide.

Key metrics

Basic
Market capitalization
$2.7m
Enterprise Value
$-5.9m
Net debt
positive
Cash
$8.5m
Shares outstanding
3.0m
Valuation
P/E
negative
P/S | estimate
88.3 | -
EV/Sales | estimate
negative | -
EV/FCF | ex SBC
1.3 | -
P/B
0.2
Financial Health
Equity Ratio
71.2%
Return on Equity
-56.6%
ROCE
-45.7%
ROIC
-
Debt/Equity
0.0
Financials
Revenue | estimate
$30.0k | $0.0
EBITDA
$-6.4m
EBIT
$-7.7m
Net Income
$-7.6m
Free Cash Flow | ex SBC
$-4.4m | -
Growth
Revenue | estimate
- | -100.0%
EBITDA
61.8%
EBIT
55.1%
Net Income
54.8%
Free Cash Flow
26.0%
Margin
Gross
-306.5%
EBITDA
-20,783.9%
EBIT
-24,703.2%
Net
-24,629.0%
Free Cash Flow | ex SBC
-14,229.0% | -
More
EPS
$-6.1
FCF per Share
$-1.5
Short interest
0.6%
Employees
4
Rev per Employee
$10.0k

PainReform Ltd Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a PainReform Ltd forecast:

3x Hold
50%
3x Sell
50%

Analyst Opinions

6 Analysts have issued a PainReform Ltd forecast:

Hold
50%
Sell
50%

Financial data from PainReform Ltd

Jun '26
+/-
%
0.03 0.03
-
100%
- Direct Costs 0.13 0.13
-
433%
-0.10 -0.10
-
-333%
- Selling and Administrative Expenses 4.41 4.41
10% 10%
14,700%
- Research and Development Expense 1.94 1.94
84% 84%
6,467%
-6.44 -6.44
62% 62%
-21,467%
- Depreciation and Amortization 1.22 1.22
618% 618%
4,067%
EBIT (Operating Income) EBIT -7.66 -7.66
55% 55%
-25,527%
Net Profit -7.64 -7.64
55% 55%
-25,467%

In millions USD.

Don't miss a Thing! We will send you all news about PainReform Ltd directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

PainReform Ltd Stock News

Neutral
GlobeNewsWire
●
4 days ago
Proposed transaction combines PRF's DeepSolar/GridFeed™ renewable energy forecasting and storage optimization platform with Dotz's AI-driven energy management technologies, creating an expanded offering across energy consumption, generation and trading
Neutral
GlobeNewsWire
●
16 days ago
Preliminary cash, including short-term deposits, of approximately $11.0 million as of September 30, 2026, and total liabilities of approximately $2.5 million
Neutral
GlobeNewsWire
●
about 2 months ago
IEA projects global data center electricity consumption to roughly double to 950 TWh by 2030, with consumption from AI-focused data centers expected to triple Company believes GridFeed's existing AI optimization engine is well suited to helping data center operators make better use of limited power capacity TEL AVIV, Israel, Sept. 16, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd.
More PainReform Ltd News

Company Profile

PainReform Ltd. operates as a pharmaceutical company. It develops and markets pharmaceuticals. The firm focuses on developing reformulation of pain therapeutics, PainReform applies its propriety formulation technologies to prolong and enhance efficacy, reduce adverse effects shortening recovery time and reduce the need of augmentation with drugs such as opioids and NSAIDS. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.

Head office Israel
CEO Mr. Hadar
Employees 4
Founded 2007
Website prf-tech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today